FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3149049984> ?p ?o ?g. }

• W3149049984 abstract "The prevalence of allergic rhinitis (AR), including symptoms of sneezing, nasal itching, airflow obstruction, and nasal discharge caused by histamine and immunoglobulin E (IgE)-mediated reactions, is ~30% in the U.S. Recent studies seem to suggest that the allergic inflammatory processes in AR may be induced by the interaction between an allergen (trigger) and the nasal microbiome (substrate). In this study, we have identified two agents with antihistaminic and microbiome-modulating characteristics that can be administered intranasally, namely, chlorpheniramine maleate (CPM) and xylitol (X). This study aimed to test the efficacy of intranasal CPM plus xylitol (CPM+X) nasal for the treatment of AR in an outpatient setting. A multicenter, randomized, double-blind, 30-day pilot study was conducted during the spring of 2019. After starting five days of placebo therapy (run-in period), patients with moderate-to-severe AR nasal symptoms were randomized to treatment with CPM+X (n=16) spray and nasal saline placebo (PLB; n=13). Both treatments were administered in the form of one spray dose (~100 µL of the solution containing 1.25 mg CPM) per nostril twice a day. Outcome variables were the changes in visual analog scale (VAS) and daily symptoms score (DSS) at days 1, 5, 10, 15, 25, and 30 after the initiation of the treatment. ANOVA (analysis of variance) with repeated revealed a significant treatment-by-time interaction such that the CPM+X group had a significant decrease (p < 0.05) in both DSS (∆-3.0 ± 2.7) and VAS (∆-3.8 ± 2.0) scores compared to PLB after 30 days. The difference in DSS and VAS scores between the groups was evident just after five days (day 10) of using CPM+X. The CPM+X scores were significantly lower (p < 0.008) starting from day 10 compared with day 1, whereas there were no statistically significant (p > 0.008) changes in the PLB during the 30-day treatment window. The present data suggest that nasal CPM+X use effectively improves AR symptoms. A large-scale study of the long-term effects of CPM+X for the treatment of other chronic respiratory disorders and the potential microbiome-modulating effects warrants further investigation." @default.
• W3149049984 created "2021-04-13" @default.
• W3149049984 creator A5013708028 @default.
• W3149049984 creator A5068646593 @default.
• W3149049984 creator A5085473047 @default.
• W3149049984 creator A5090804516 @default.
• W3149049984 date "2021-03-31" @default.
• W3149049984 modified "2023-10-03" @default.
• W3149049984 title "A Randomized Controlled Pilot Trial to Test the Efficacy of Intranasal Chlorpheniramine Maleate With Xylitol for the Treatment of Allergic Rhinitis" @default.
• W3149049984 cites W1489672323 @default.
• W3149049984 cites W188765527 @default.
• W3149049984 cites W1977594314 @default.
• W3149049984 cites W1982775285 @default.
• W3149049984 cites W1994864348 @default.
• W3149049984 cites W2000366267 @default.
• W3149049984 cites W2017760925 @default.
• W3149049984 cites W2104304260 @default.
• W3149049984 cites W2116187491 @default.
• W3149049984 cites W2165365040 @default.
• W3149049984 cites W2325918582 @default.
• W3149049984 cites W2733431405 @default.
• W3149049984 cites W2767111875 @default.
• W3149049984 cites W2884138484 @default.
• W3149049984 cites W2899959274 @default.
• W3149049984 cites W3046962729 @default.
• W3149049984 cites W3082594465 @default.
• W3149049984 doi "https://doi.org/10.7759/cureus.14206" @default.
• W3149049984 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8010914" @default.
• W3149049984 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33816038" @default.
• W3149049984 hasPublicationYear "2021" @default.
• W3149049984 type Work @default.
• W3149049984 sameAs 3149049984 @default.
• W3149049984 citedByCount "2" @default.
• W3149049984 countsByYear W31490499842022 @default.
• W3149049984 countsByYear W31490499842023 @default.
• W3149049984 crossrefType "journal-article" @default.
• W3149049984 hasAuthorship W3149049984A5013708028 @default.
• W3149049984 hasAuthorship W3149049984A5068646593 @default.
• W3149049984 hasAuthorship W3149049984A5085473047 @default.
• W3149049984 hasAuthorship W3149049984A5090804516 @default.
• W3149049984 hasBestOaLocation W31490499841 @default.
• W3149049984 hasConcept C126322002 @default.
• W3149049984 hasConcept C141071460 @default.
• W3149049984 hasConcept C14184104 @default.
• W3149049984 hasConcept C142724271 @default.
• W3149049984 hasConcept C168563851 @default.
• W3149049984 hasConcept C185592680 @default.
• W3149049984 hasConcept C203014093 @default.
• W3149049984 hasConcept C204787440 @default.
• W3149049984 hasConcept C207480886 @default.
• W3149049984 hasConcept C27081682 @default.
• W3149049984 hasConcept C2777768476 @default.
• W3149049984 hasConcept C2778311950 @default.
• W3149049984 hasConcept C2779279117 @default.
• W3149049984 hasConcept C2779789940 @default.
• W3149049984 hasConcept C2780510475 @default.
• W3149049984 hasConcept C2780973058 @default.
• W3149049984 hasConcept C2908541515 @default.
• W3149049984 hasConcept C42219234 @default.
• W3149049984 hasConcept C43617362 @default.
• W3149049984 hasConcept C504460877 @default.
• W3149049984 hasConcept C71924100 @default.
• W3149049984 hasConcept C85663871 @default.
• W3149049984 hasConceptScore W3149049984C126322002 @default.
• W3149049984 hasConceptScore W3149049984C141071460 @default.
• W3149049984 hasConceptScore W3149049984C14184104 @default.
• W3149049984 hasConceptScore W3149049984C142724271 @default.
• W3149049984 hasConceptScore W3149049984C168563851 @default.
• W3149049984 hasConceptScore W3149049984C185592680 @default.
• W3149049984 hasConceptScore W3149049984C203014093 @default.
• W3149049984 hasConceptScore W3149049984C204787440 @default.
• W3149049984 hasConceptScore W3149049984C207480886 @default.
• W3149049984 hasConceptScore W3149049984C27081682 @default.
• W3149049984 hasConceptScore W3149049984C2777768476 @default.
• W3149049984 hasConceptScore W3149049984C2778311950 @default.
• W3149049984 hasConceptScore W3149049984C2779279117 @default.
• W3149049984 hasConceptScore W3149049984C2779789940 @default.
• W3149049984 hasConceptScore W3149049984C2780510475 @default.
• W3149049984 hasConceptScore W3149049984C2780973058 @default.
• W3149049984 hasConceptScore W3149049984C2908541515 @default.
• W3149049984 hasConceptScore W3149049984C42219234 @default.
• W3149049984 hasConceptScore W3149049984C43617362 @default.
• W3149049984 hasConceptScore W3149049984C504460877 @default.
• W3149049984 hasConceptScore W3149049984C71924100 @default.
• W3149049984 hasConceptScore W3149049984C85663871 @default.
• W3149049984 hasLocation W31490499841 @default.
• W3149049984 hasLocation W31490499842 @default.
• W3149049984 hasOpenAccess W3149049984 @default.
• W3149049984 hasPrimaryLocation W31490499841 @default.
• W3149049984 hasRelatedWork W159265166 @default.
• W3149049984 hasRelatedWork W1966834903 @default.
• W3149049984 hasRelatedWork W1968210320 @default.
• W3149049984 hasRelatedWork W2054279456 @default.
• W3149049984 hasRelatedWork W2073444018 @default.
• W3149049984 hasRelatedWork W2095982748 @default.
• W3149049984 hasRelatedWork W2171886536 @default.
• W3149049984 hasRelatedWork W2770624586 @default.
• W3149049984 hasRelatedWork W3149049984 @default.
• W3149049984 hasRelatedWork W4243470352 @default.
• W3149049984 isParatext "false" @default.

• next